In this study, we found that FAM117B disrupted KEAP1-NRF2 interaction through its ETGE motif, which reduced the degradation of NRF2 and activated KEAP1/NRF2 signaling, and ultimately promoted the growth and chemoresistance of gastric cancer cells. Here, KEAP1 is linked to gastric cancer.